The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Kolmakova K.A.

Kirov Military Medical Academy

Emelin A.Yu.

S.M. Kirov Military Medical Academy;
Saint Petersburg State University

Lobzin V.Yu.

S.M. Kirov Military Medical Academy;
Saint Petersburg State University

Bodrova T.V.

S.M. Kirov Military Medical Academy

Litvinenko I.V.

Kirov Military Medical Academy

Sleep disorders in patients with Lewy body dementia and Parkinson’s disease

Authors:

Kolmakova K.A., Emelin A.Yu., Lobzin V.Yu., Bodrova T.V., Litvinenko I.V.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2025;125(4‑2): 81‑87

DOI: 10.17116/jnevro202512504281

Read: 1170 times

Buy for 300₽
Contact the author
Table of contents

SLEEP DISORDERS IN PATIENTS WITH LEWY BODY DEMENTIA AND PARKINSON’S DISEASE
SLEEP DISORDERS IN PATIENTS WITH LEWY BODY DEMENTIA AND PARKINSON’S DISEASE

To cite this article:

Kolmakova KA, Emelin AYu, Lobzin VYu, Bodrova TV, Litvinenko IV. Sleep disorders in patients with Lewy body dementia and Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;125(4‑2):81‑87. (In Russ.)
https://doi.org/10.17116/jnevro202512504281

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))
МСФ на ЯМ
Использование инфографики авторами научных работ
Recommended articles:
Neurochemical mechanisms of tremor in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):64-72
Clinical presentation and diagnosis of Parkinson’s disease in patients with schi­zophrenia spectrum diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):73-80
Cognitive impairment in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):81-90
Bladder dysfunction in patients with stages I—III of Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):91-99
Chro­nic epidural spinal cord stimulation for gait impairments in Parkinson’s disease and atypical parkinsonism. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):100-112
Carbonyl stress in meno­pausal women with inso­mnia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):192-197
Subjective sleep quality evaluation in patients with neuromyelitis optica spectrum diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):57-61
A portrait of a doctor with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):160-164
The Rela­tionship of obstructive sleep apnea with paro­xysmal atrial fibrillation in women suffered coro­nary heart disease and arte­rial hype­rtension. Russian Journal of Preventive Medi­cine. 2025;(2):61-66
Pathomorphosis of the Parkinson’s disease against the background of DBS STN. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):21-27
Abstract:

The article discusses the features of sleep disorders in patients with Lewy body dementia and Parkinson’s disease. The focus is on behavioral disorders during the rapid eye movement phase, which are manifested by active movements and aggressive sleep behavior, as well as other sleep disorders, such as insomnia and excessive daytime sleepiness. The mechanisms of development of these disorders and their impact on the quality of life of patients and their relatives are described. Current approaches to diagnosing and treating these conditions, including pharmacotherapy and non-drug correction methods, are discussed.

Keywords:

Lewy body dementia
Parkinson’s disease
alpha-synucleinopathies
excessive daytime sleepiness
insomnia
obstructive sleep apnea
rapid eye movement phase behavior disorders

Authors:

Kolmakova K.A.

Kirov Military Medical Academy

Emelin A.Yu.

S.M. Kirov Military Medical Academy;
Saint Petersburg State University

Lobzin V.Yu.

S.M. Kirov Military Medical Academy;
Saint Petersburg State University

Bodrova T.V.

S.M. Kirov Military Medical Academy

Litvinenko I.V.

Kirov Military Medical Academy

Received:

28.01.2025

Accepted:

29.01.2025

Close metadata

References:

  1. Schenck CH, Bundlie SR, Mahowald MW. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. Neurology. 1996;46(2):388-393.  https://doi.org/10.1212/wnl.46.2.388
  2. Boeve B, Silber M, Saper C, et al. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain. 2007;130:2770-2788. https://doi.org/10.1093/brain/awm056
  3. Postuma R, Gagnon J, Vendette M, et al. Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology. 2009;72:1296-1300. https://doi.org/10.1212/01.wnl.0000340980.19702.6e
  4. Boeve B. REM sleep behavior disorder: updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions. Ann NY Acad Sci. 2010;1184:17-56.  https://doi.org/10.1111/j.1749-6632.2009.05115.x
  5. Claassen D, Josephs K, Ahlskog J, et al. REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century. Neurology. 2010;75:494-499.  https://doi.org/10.1212/WNL.0b013e3181ec7fac
  6. Schenck CH, Boeve BF, Mahowald MW. Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series. Sleep Med. 2013;14(8):744-748.  https://doi.org/10.1016/j.sleep.2012.10.009
  7. McCarter SJ, St Louis EK, Sandnessd DJ, et al. Antidepressants increase REM sleep muscle tone in patients with and without REM sleep behavior disorder. Sleep. 2015;38(6):907-917.  https://doi.org/10.5665/sleep.4738
  8. Friedman J. Presumed rapid eye movement behavior disorder in Machado-Joseph disease (spinocerebellar ataxia type 3). Mov Disord. 2002;17:1350-1353. https://doi.org/10.1002/mds.10269
  9. Iranzo A, Muñoz E, Santamaria J, et al. REM sleep behavior disorder and vocal cord paralysis in Machado-Joseph disease. Mov Disord. 2003;18:1179-1183. https://doi.org/10.1002/mds.10509
  10. Arnulf I, Nielsen J, Lohmann E, et al. Rapid eye movement sleep disturbances in Huntington disease. Arch Neurol. 2008;65:482-488.  https://doi.org/10.1001/archneur.65.4.482
  11. Gagnon J, Petit D, Fantini M, et al. REM sleep behavior disorder and REM sleep without atonia in probable Alzheimer disease. Sleep. 2006;29:1321-1325. https://doi.org/10.1093/sleep/29.10.1321
  12. Mahlknecht P, Iranzo A, Stefani A, et al. Caveats of Neurodegenerative Risk Stratification in Idiopathic REM Sleep Behavior Disorder by Use of the MDS Research for Prodromal Parkinson’s Disease. Sleep. 2017;40(10):34-39.  https://doi.org/10.1093/sleep/zsx131
  13. Iranzo A, Fernández-Arcos A, Tolosa E, et al. Neurodegenerative disorder risk in idiopathic REM sleep behavior disorder: study in 174 patients. PLoS One. 2014;9(2):e89741. https://doi.org/10.1371/journal.pone.0089741
  14. Wing YK, Li SX, Mok V, et al. Prospective outcome of rapid eye movement sleep behaviour disorder: psychiatric disorders as a potential early marker of Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2012;83:470-472.  https://doi.org/10.1136/jnnp-2011-301232
  15. Boot BP, Boeve BF, Roberts RO, et al. Probable rapid eye movement sleep behavior disorder increases risk for mild cognitive impairment and Parkinson disease: a population-based study. Ann Neurol. 2012;71:49-56.  https://doi.org/10.1002/ana.22655
  16. Postuma RB, Gagnon JF, Montplaisir JY. REM Sleep Behavior Disorder and Prodromal Neurodegeneration — Where Are We Headed? Tremor Other Hyperkinet Mov. 2013;3:34-39. 
  17. Postuma RB, Arnulf I, Hogl B, et al. A single-question screen for rapid eye movement sleep behavior disorder: a multicenter validation study. Mov Disord. 2012;27(7):913-916.  https://doi.org/10.1002/mds.25037
  18. Sateia MJ. International classification of sleep disorders-third edition: highlights and modifications. Chest. 2014;146(5):1387-1394. https://doi.org/10.1378/chest.14-0970
  19. Gilat M, Coeytaux Jackson A, Marshall NS, et al. Melatonin for rapid eye movement sleep behavior disorder in Parkinson’s disease: a randomised controlled trial. Mov Disord. 2020;35:344-349.  https://doi.org/10.1002/mds.27886
  20. Clinical recommendations «Cognitive disorders in elderly and senile patients». S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(10-3):6-137. (In Russ.). https://doi.org/10.17116/jnevro20211211036
  21. Gilat M, Marshall NS, Testelmans D, et al. A critical review of the pharmacological treatment of REM sleep behavior disorder in adults: time for more and larger randomized placebocontrolled trials. J Neurol. 2022;269:125-148.  https://doi.org/10.1007/s00415-020-10353-0
  22. Taylor JP, Mckeith IG, Burn DJ, et al. New evidence on the management of Lewy body dementia. Lancet Neurol. 2020;19:157-169.  https://doi.org/10.1016/S1474-4422(19)30153-X
  23. Larsson V, Aarsland D, Ballard C, et al. The effect of memantine on sleep behaviour in dementia with Lewy bodies and Parkinson’s disease dementia. Int J Geriatr Psychiatry. 2010;25(10):1030-1038. https://doi.org/10.1002/gps.2506
  24. Di Giacopo R, Fasano A, Quaranta D, et al. Rivastigmine as alternative treatment for refractory REM behavior disorder in Parkinson’s disease. Mov Disord. 2012;27:559-561.  https://doi.org/10.1002/mds.24909
  25. Gjerstad MD, Wentzel-Larsen T, Aarsland D, Larsen JP. Insomnia in Parkinson’s disease: frequency and progression over time. J Neurol Neurosurg Psychiatry. 2007;78:476-479.  https://doi.org/10.1136/jnnp.2006.100370
  26. Tholfsen LK, Larsen JP, Schulz J, et al. Changes in insomnia subtypes in early Parkinson disease. Neurology. 2017;88:352-358. 
  27. Lyashenko EA, Poluektov MG, Levin OS. Sleep and wakefulness disorders in Parkinson’s disease. Effective Pharmacotherapy. 2013;12:72-80. (In Russ.).
  28. Pao WC, Boeve BF, Ferman TJ, et al. Polysomnographic findings in dementia with Lewy bodies. Neurologist. 2013;19:1-6.  https://doi.org/10.1097/NRL.0b013e31827c6bdd
  29. Bugalho P, Salavisa M, Marto JP, et al. Polysomnographic data in Dementia with Lewy Bodies: correlation with clinical symptoms and comparison with other alpha-synucleinopathies. Sleep Med. 2019;55:62-68.  https://doi.org/10.1016/j.sleep.2018.12.006
  30. Gvilia I, Xu F, Mcginty D, Szymusiak R. Homeostatic regulation of sleep: a role for preoptic area neurons. J Neurosci. 2006;26:9426-9433. https://doi.org/10.1523/JNEUROSCI.2012-06.2006
  31. Lim ASP, Ellison BA, Wang JL, et al. Sleep is related to neuron numbers in the ventrolateral preoptic/intermediate nucleus in older adults with and without Alzheimer’s disease. Brain. 2014;137:2847-2861. https://doi.org/10.1093/brain/awu222
  32. Willison LD, Kudo T, Loh DH, et al. Circadian dysfunction may be a key component of the non-motor symptoms of Parkinson’s disease: insights from a transgenic mouse model. Exp Neurol. 2013;243:57-66.  https://doi.org/10.1016/j.expneurol.2013.01.014
  33. De Pablo-Fernández E, Courtney R, Warner TT, Holton JL. A histologic study of the circadian system in Parkinson disease, multiple system atrophy, and progressive supranuclear palsy. JAMA Neurol. 2018;75:1008-1012. https://doi.org/10.1001/jamaneurol.2018.0640
  34. Ahn JH, Kim M, Park S, et al. Prolonged-release melatonin in Parkinson’s disease patients with a poor sleep quality: A randomized trial. Parkinsonism Relat Disord. 2020;75:50-54.  https://doi.org/10.1016/j.parkreldis.2020.03.029
  35. Menza M, Dobkin RD, Marin H, et al. Treatment of insomnia in Parkinson’s disease: a controlled trial of eszopiclone and placebo. Mov Disord. 2010;25:1708-1714. https://doi.org/10.1002/mds.23168
  36. Edwards K, Royall D, Hershey L, et al. Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 24-week openlabel study. Dement Geriatr Cogn Disord. 2007;23:401-405.  https://doi.org/10.1159/000101512
  37. Litvinenko IV, Odinak MM, Mogil’naya VI, Emelin AY. Efficacy and safety of galantamine (reminyl) for dementia in patients with Parkinson’s disease (an open controlled trial). Neurosci Behav Physiol. 2008;38:937-945.  https://doi.org/10.1007/s11055-008-9077-3
  38. Boddy F, Rowan EN, Lett D, et al. Subjectively reported sleep quality and excessive daytime somno-lence in Parkinson’s disease with and without dementia, dementia with Lewy bodies and Alzheimer’s disease. Int J Geriatr Psychiatry. 2007;22:529-535.  https://doi.org/10.1002/gps.1709
  39. Boeve A, Ferman TJ, Aakre J, et al. Excessive daytime sleepiness in major dementia syndromes. Am J Alzheimers Dis Other Demen. 2019;34:261-264.  https://doi.org/10.1177/1533317519828046
  40. O’dowd S, Schumacher J, Burn DJ, et al. Fluctuating cognition in the Lewy body dementias. Brain. 2019;142:3338-3350. https://doi.org/10.1093/brain/awz235
  41. Lu J, Jhou TC, Saper CB. Identification of wake-active dopaminergic neurons in the ventral periaqueductal gray matter. J Neurosci. 2006;26:193-202.  https://doi.org/10.1523/JNEUROSCI.2244-05.2006
  42. Weintraub D, Mavandadi S, Mamikonyan E, et al. Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease. Neurology. 2010;75:448-455.  https://doi.org/10.1212/WNL.0b013e3181ebdd79
  43. Cochen De Cock V, Abouda M, Leu S, et al. Is obstructive sleep apnea a problem in Parkinson’s disease? Sleep Med. 2010;11:247-252.  https://doi.org/10.1016/j.sleep.2009.05.008
  44. Terzaghi M, Arnaldi D, Rizzetti MC, et al. Analysis of videopolysomnographic sleep findings in dementia with Lewy bodies. Mov Disord. 2013;28:1416-1423. https://doi.org/10.1002/mds.25523
  45. PrestiMF, Schmeichel AM, Low PA, et al. Degeneration of brainstem respiratory neurons in dementia with Lewy bodies. Sleep. 2014;37:373-378.  https://doi.org/10.5665/sleep.3418
  46. Iranzo A, Santamaría J. Severe obstructive sleep apnea/hypopnea mimicking REM sleep behavior disorder. Sleep. 2005;28:203-206.  https://doi.org/10.1093/sleep/28.2.203
  47. Chung F, Abdullah HR, Liao P. STOP-bang questionnaire: a practical approach to screen for obstructive sleep apnea. Chest. 2016;149:631-638.  https://doi.org/10.1378/chest.15-0903
  48. Neikrug AB, Liu L, Avanzino JA, et al. Continuous positive airway pressure improves sleep and daytime sleepiness in patients with Parkinson disease and sleep apnea. Sleep. 2014;37:177-185. 
  49. Kaminska M, Mery VP, Lafontaine AL, et al. Change in cognition and other non-motor symptoms with obstructive sleep apnea treatment in Parkinson disease. J Clin Sleep Med. 2018;14:819-828. 
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.